https://www.selleckchem.com/pr....oducts/Floxuridine.h
ches are not an optimal option for a difficult clinical decision regarding step-up therapy. More specifically, negative class labels in step-up therapy data are not a robust ground truth, because the costs and risks associated with higher line of therapy impact objective decision making of patients and providers. The proposed semi-supervised learning approach can be applied to other step-up therapy applications. This study showed that supervised learning approaches are not an optimal option for a difficult clinical decision regardin